Gabapentin use and a claim for memory loss in Massachusetts

Massachusetts is a premier jurisdiction for pharmaceutical litigation, combining world-class academic medical institutions — Harvard, Mass General Brigham, Boston University, and Tufts — with experienced mass tort judges and a strong plaintiff bar. The state's opioid crisis was among the most severe nationally, particularly in cities like Fall River, New Bedford, and Worcester, driving aggressive gabapentin prescribing as clinicians sought alternatives. Massachusetts has not scheduled gabapentin as a controlled substance but maintains a robust PDMP. The state's 3-year SOL and strong consumer protection laws (Chapter 93A) provide additional legal theories for gabapentin cognitive decline claims beyond traditional product liability.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Massachusetts.